- Focal Fatty Change of the Liver
-
Yoon JH, Park CI, Chung KS
- KMID: 1095749
- Yonsei Med J.
- 1987 Dec;28(4):322-325.
- doi: 10.3349/ymj.1987.28.4.322
Focal fatty change of the liver is a nodular lesion which is a rarely described and poorly characterized entity. The hepatic nodule measured 1.4cm at its maximum diameter, was subcapsular... -
- CITED
-
- Close
- SHARE
-
- Close
- Transient elastography, true or false?
-
Seo YS
- KMID: 1384050
- Korean J Hepatol.
- 2009 Dec;15(4):431-437.
- doi: 10.3350/kjhep.2009.15.4.431
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Current status of liver disease in Korea: Nonalcoholic fatty liver disease
-
Park SH
- KMID: 853305
- Korean J Hepatol.
- 2009 Dec;15(Suppl 6):S34-S39.
- doi: 10.3350/kjhep.2009.15.S6.S34
Recently, obesity (BMI > or =25 kg/m2) and type II diabetes mellitus have reached epidemic proportions in Korea, and rates of nonalcoholic fatty liver disease (NAFLD) are between 10% and... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of weight control on hepatic abnormalities in obese patients with fatty liver
-
Park HS, Kim MW, Shin ES
- KMID: 927172
- J Korean Med Sci.
- 1995 Dec;10(6):414-421.
- doi: 10.3346/jkms.1995.10.6.414
This study was aimed at finding out whether weight reduction alone can improve liver function in obese patients with fatty liver. We did a longitudinal, clinical intervention study on weight... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Characteristics of Health Screen Examinees with Nonalcoholic Fatty Liver and Normal Liver Function Test
-
Lee SY, Kim SK, Kwon CI, Kim MJ, Kang MS, Ko KH, Hong SP, Hwang SG, Park PW, Rim KS
- KMID: 1767620
- Korean J Gastroenterol.
- 2008 Sep;52(3):161-170.
BACKGROUND/AIMS: Nonalcoholic fatty liver disease (NAFLD) is known to be closely associated with various metabolic abnormalities including metabolic syndrome. However, there are few data available on the association of metabolic... -
- CITED
-
- Close
- SHARE
-
- Close
- Association of Hepatic Iron Deposition and Serum Iron Indices with Hepatic Inflammation and Fibrosis Stage in Nonalcoholic Fatty Liver Disease
-
Moon JH, Park SH, Oh KC, Jung JO, Shin WG, Kim JP, Kim KO, Park CH, Hahn T, Yoo KS, Kim JH, Kim DJ, Lee MS, Park CK, Jun SY
- KMID: 772970
- Korean J Gastroenterol.
- 2006 Jun;47(6):432-439.
BACKGROUND/AIMS: Nonalcoholic steatohepatitis can develop from nonalcoholic fatty liver and progress to severe liver disease such as cirrhosis. The mechanism determining the progression from fatty liver to steatohepatitis is... -
- CITED
-
- Close
- SHARE
-
- Close
- Is the Prevalence of Cryptogenic Hepatocellular Carcinoma Increasing in Korea?
-
Oh KC, Park SH, Park JC, Jin DK, Park CS, Kim KO, Jang HJ, Lee JY, Park CH, Han TH, Yoo KS, Kim JH, Kim DJ, Lee MS, Park CK
- KMID: 772716
- Korean J Gastroenterol.
- 2005 Jan;45(1):45-51.
BACKGROUND/AIMS: Nonalcoholic fatty liver disease (NAFLD) has been characterized by a wide spectrum of liver damages that span from steatosis to cryptogenic liver cirrhosis and even to hepatocellular carcinoma... -
- CITED
-
- Close
- SHARE
-
- Close
- Validation of P2/MS and Other Noninvasive Fibrosis Scoring Systems in the Korean Population with Nonalcoholic Fatty Liver Disease
-
Yu SJ, Kim D, Lee JH, Chung GE, Yim JY, Park MJ, Kim YJ, Yoon JH, Jang JJ, Lee HS
- KMID: 991464
- Korean J Gastroenterol.
- 2011 Jan;57(1):19-27.
- doi: 10.4166/kjg.2011.57.1.19
BACKGROUND/AIMS: P2/MS is a noninvasive marker for detecting hepatic fibrosis in patients with viral hepatitis. However, the applicability of P2/MS in patients with nonalcoholic fatty liver disease (NAFLD) has not... -
- CITED
-
- Close
- SHARE
-
- Close
- Usefulness of Non-invasive Markers for Predicting Significant Fibrosis in Patients with Chronic Liver Disease
-
Lee HH, Seo YS, Um SH, Won NH, Yoo H, Jung ES, Kwon YD, Park S, Keum B, Kim YS, Yim HJ, Jeen YT, Chun HJ, Kim CD, Ryu HS
- KMID: 1713834
- J Korean Med Sci.
- 2010 Jan;25(1):67-74.
- doi: 10.3346/jkms.2010.25.1.67
The purpose of this prospective study was to verify and compare the strengths of various blood markers and fibrosis models in predicting significant liver fibrosis. One hundred fifty-eight patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- Sonography of hepatic hemangioma accompanied by arterioportal shunt
-
Choi SH, Kim KW, Hong GS, Lee SJ, Kim SY, Lee JS, Kim HJ
- KMID: 1737604
- Clin Mol Hepatol.
- 2014 Mar;20(1):85-87.
- doi: 10.3350/cmh.2014.20.1.85
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease
-
Kwak MS, Kim D, Chung GE, Kang SJ, Park MJ, Kim YJ, Yoon JH, Lee HS
- KMID: 1410895
- Clin Mol Hepatol.
- 2012 Dec;18(4):383-390.
- doi: 10.3350/cmh.2012.18.4.383
BACKGROUND/AIMS: Serum bilirubin exerts antioxidant and cytoprotective effects. In addition, elevated serum bilirubin levels are associated with a decreased risk of metabolic and cardiovascular diseases. However, few studies have evaluated... -
- CITED
-
- Close
- SHARE
-
- Close
- What we need to know when performing and interpreting US elastography
-
Park SH, Kim SY, Suh CH, Lee SS, Kim KW, Lee SJ, Lee MG
- KMID: 2373143
- Clin Mol Hepatol.
- 2016 Sep;22(3):406-414.
- doi: 10.3350/cmh.2016.0106
According to the increasing need for accurate staging of hepatic fibrosis, the ultrasound (US) elastography techniques have evolved significantly over the past two decades. Currently, US elastography is increasingly used... -
- CITED
-
- Close
- SHARE
-
- Close
- Elevated red cell distribution width is associated with advanced fibrosis in NAFLD
-
Kim HM, Kim BS, Cho YK, Kim BI, Sohn CI, Jeon WK, Kim HJ, Park DI, Park JH, Joo KJ, Kim CJ, Kim YS, Heo WJ, Choi WS
- KMID: 1705203
- Clin Mol Hepatol.
- 2013 Sep;19(3):258-265.
- doi: 10.3350/cmh.2013.19.3.258
BACKGROUND/AIMS: The red-blood-cell distribution width (RDW) is a newly recognized risk marker in patients with cardiovascular disease, but its role in nonalcoholic fatty liver disease (NAFLD) has not been well... -
- CITED
-
- Close
- SHARE
-
- Close
